A rapid homogeneous immunoassay to quantify gemcitabine in plasma for therapeutic drug monitoring (TDM)

BACKGROUND: Gemcitabine (2′,2′-difluoro-2′-deoxycytidine) is a nucleoside analog used as a single agent and in combination regimens for the treatment of a variety of solid tumors. Several studies have shown a relationship between gemcitabine peak plasma concentration (C(max)) and hematological toxic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Drug Monit
Asıl Yazarlar: Kozo, Daniel, Ross, Matt W., Jarrah, Justin, Barrett, Michael, Harney, Rebecca L., Courtney, Jodi B., Baburina, Irina, Holleran, Julianne L., Beumer, Jan H., Peters, Godefridus J., Honeywell, Richard J., Salamone, Salvatore J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5460533/
https://ncbi.nlm.nih.gov/pubmed/28490046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000402
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller